These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3604740)

  • 21. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ; Mandel FS; Schweizer E
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alprazolam in the treatment of neurotic anxiety.
    Kerry RJ; McDermott CM
    Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alprazolam and amitriptyline in the treatment of moderate depression.
    Lapierre YD; Browne M; Oyewumi K; Sarantidis D
    Int Clin Psychopharmacol; 1994; 9(1):41-5. PubMed ID: 8195582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
    J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alprazolam effects in children with anxiety disorders.
    Simeon JG; Ferguson HB
    Can J Psychiatry; 1987 Oct; 32(7):570-4. PubMed ID: 3315169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxazepam-protriptyline: a double-blind phase II evaluation of the efficacy and safety of the combination versus placebo in neurotic, depressed and anxious psychiatric outpatients.
    Gilbert MM; Koepke HH
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):825-38. PubMed ID: 813948
    [No Abstract]   [Full Text] [Related]  

  • 28. [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression].
    Bernardi F; Cairoli S; D'Aurizio C; De Rosa A; Grasso A; Sannino V; Savoldi F; Sorge F; Casadei GL
    Minerva Psichiatr; 1988; 29(4):203-10. PubMed ID: 3074234
    [No Abstract]   [Full Text] [Related]  

  • 29. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alprazolam compared to amitriptyline in the treatment of major depression.
    Eriksson B; Nagy A; Starmark JE; Thelander U
    Acta Psychiatr Scand; 1987 Jun; 75(6):656-63. PubMed ID: 3618289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.
    Lustman PJ; Griffith LS; Clouse RE; Freedland KE; Eisen SA; Rubin EH; Carney RM; McGill JB
    Diabetes Care; 1995 Aug; 18(8):1133-9. PubMed ID: 7587848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
    Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter controlled study of oxazepam in anxious elderly outpatients.
    Koepke HH; Gold RL; Linden ME; Lion JR; Rickels K
    Psychosomatics; 1982 Jun; 23(6):641-5. PubMed ID: 6750675
    [No Abstract]   [Full Text] [Related]  

  • 34. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.
    Chouinard G; Annable L; Fontaine R; Solyom L
    Psychopharmacology (Berl); 1982; 77(3):229-33. PubMed ID: 6126907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS; Woods SW
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial.
    Stein DJ
    Adv Ther; 2015 Jan; 32(1):57-68. PubMed ID: 25620535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
    Frattola L; Garreau M; Piolti R; Bassi S; Albizzati MG; Borghi C; Morselli PL
    Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-reports of anxiety level and EEG changes after a single dose of benzodiazepines. Double-blind comparison of two forms of oxazepam.
    Ansseau M; Doumont A; Cerfontaine JL; Mantanus H; Rousseau JC; Timsit Berthier M
    Neuropsychobiology; 1984; 12(4):255-9. PubMed ID: 6398863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.